by TractManager | Feb 14, 2017 | Emerging Technology Report
An intravenous programmed death ligand 1 checkpoint inhibitor for treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy, and for patients who have disease...
by TractManager | Feb 9, 2017 | Health Technology Assessment
Purpose of Technology: Coronary artery calcium (CAC) scoring uses computed tomography scanning to detect and assess the extent of atherosclerosis and quantifies the findings using a scoring system to assess and stratify risk of coronary artery disease in asymptomatic...
by TractManager | Feb 2, 2017 | Clinical Utility Evaluation
This report examines the clinical utility of PTEN genetic testing of patients at risk for, or diagnosed with, PTEN hamartoma tumor syndrome (PHTS) based upon clinical symptoms, with or without a family history suggestive of PHTS. The goal of this report is to assess...
by TractManager | Feb 1, 2017 | Emerging Technology Report
An intravenously administered, single-dose monoclonal antibody intended to reduce recurrence of Clostridium difficile infection (CDI) in adult patients receiving antibacterial drug treatment for CDI who are at high risk for recurrence.If you have a Hayes login,...
Recent Comments